Just stating fact. Consider what part of the econ., in dollars, is represented by the oil industry - the price of oil. The no.'s are just irrefutable.
Do HF's own blue chip stocks?
Sanders is a Social Democrat.
Look at world currencies during the last depression. Look at the nordic economies during that time. I'll give you that Iceland was an outlier, their 300,000 inhabitants were basically victims of a scheme
W, in one of his first moves as prez, sent the surplus he inherited, in the form of checks, back to the public. 90 percent going to the top 5, that's about 36 percent to the Walton family. Then he cut taxes and fought two wars off the nothing-but-increasingly-dismal books.
Those are facts. Here's one more: By any measure, most are better off than they were 7 years ago - including Big Business.
Congrats to everyone not a Walton.
By actual measure the market is being effected by oil, it's the simplest math. HF's, with all their exposure to everything petro have created a cascade of selling sector by sector, while not locking in their blue-chip losses. This most speculative sector has suffered most. NVAX, being 80% institutionally owned, represented in a lot of indexes, and victim of the resultant manipulation thats been obvious since November, leaves them prone on many fronts.
With the absolute devestation that "W" did to our economy as well as our surplus and treasure, I don't think Sanders can look as threatening, especially since he leads no party.
I'm gonna make a factual statement now. Sanders is a Social Democracrat who favors an economy like Norway, Denmark and Sweden, all of which fared better during, or didn't go through the last recession. All of their currencies actually became a safe haven with Norway 2nd to Australia for best performing, even though they have the second highest healthcare costs (cradle to grave for everyone) as percentage of gdp (9 percent). We all know who's first by more than double. If it's between him and Cruz, I'd vote for him.
Good one. That's the most likely scenario - barring news.
I'm just wondering when a turn might happen. Nvax has become more tied to the general mkt., and no amout of posititive earnings reports or tasty ratios seems to be able to stop this. We were detached from the world markets (somewhat) for a while but I guess oil was the last straw...
My (limited) knowledge is that insect bourne, and many mammalian, viruses are very difficult to fight through vaccine (see malaria, lyme, rabies, chikungunya, etc.) I could start an explanation but there are others here that might be better equipped.
One thing that hasn't been pointed out about Zika is that exposure seems to produce a level of immunity over a population. Perhaps once this virus becomes pandemic in all the tropical zones, it might, eventually, become much more rare. That's something anyway....
Jeez, you have a particular talent for misrepresenting what I say. My response was essentially that I have an OPINION as opposed to your sense of God-head. I also pointed out that you, as you've demonstrated once more, have to twist things to support your acerbic narrative. Your post might have substance but it pertains little to what I've said
It just goes down as my own opinion, I don't pretend to have absolute authority on anything but I can't think of a reasonable argument to say they would still be an early PIII co. if they just focused on one or two products. It's just common sense.
Guess that was after they went from under a dollar to seven within weeks in 2008(?). Actually, until recently they have risen pretty steadily but not in a fashion that fit my strategy of playing the normal cycles. I kept a larger core position though, b/c I've always loved the tech being was familiar with the concept through my dad's work.
yeah, it's personal.
hc, I thought about pre-writing your response - I should/ve, you're so predictable as well as strident. I treat the "statement" in the very next sentence. cosequences are consequences, predictable or not. In terms of there "unique" (your word) characteristics, very few companies are so well funded before they finish a PII (before you knee-jerk, I know they are out of PII at this point) that's the only part of NVAX that approaches unique, and it does make a dif. You go on to assume that I "think they can only do one thing at a time", obviously they can. It's that choice I'm arguing against. Nor did I mention that RSV could've been sped up, you did. Seasonal flu vaccine is a different story. You assume a lot to be so continuously contentious - a flawed strategy which, from reading most of your other posts, is your particular pompous MO.
"Specific notion" indeed, you've created most of this arguement from me to satisfy your own need to be pedantic. Someone who likes there own aroma so much can never be successfully superior no matter how much they want it, sorry.
I'm in love with their technology and loathe their management, particularly for diffusing the focus when they took over. They have only themselves to blame for what's happening now. Perhaps it would've taken extreme foresight to predict this manipulative shytestorm but focusing on, sa,y a seasonal flu and/or elderly RSV would've made them a profitable company by now with a bright patent-protected future. jmho
BTW, anybody noticed Chesapeake? Down 50% right now and trading halted several times today...
Maybe it's time to convert my jeep to NG.
Certainly the US econ. has even shown strength. And discretionary spending is really gonna start to look awesome going forward. The oil mkt. has triggered this stupid cascade, and masked/enhanced what's being done to NVAX. Add to that, the fact that speculative biotech is always the first to suffer with the onset of this kind of market.
I wonder what impact new Iranian oil will have on OPEC's ability to cut back, if thats the case...
The way Blackrock seems to function, I bet they've been dumping too.
As an aside, these places are where some ammo comes from if there were a raid. HTakeovers are talked about much much more than they ever happen though. I'd give odds that it won't happen here no matter how attractive this company is.
It is oversold, the whole market is oversold IMO. But I still wouldn't be a buyer. this is a rare instance where one could get on board after it's started to turn.
I'm not saying that isn't going on but it could very well be the case that some HF's and large holders are cutting and fleeing this space wholesale. The market sucks to begin with, and this sector is sucking worst of all. It's a good strategy that would seem to have worked, in this case, for everybody.
I'm not addressing that question, and I can't answer it. But 300 million is not a significant amount compared to the potential here, not to mention the billions in profits for many large pharma's.
How many doses of RSV vax do you think would cover that?